Welcome to the EcLiPSE Study Website  

Emergency Treatment with Levetiracetam or Phenytoin in Status Epilepticus in Children – an open label randomised controlled trial

Recruitment to EcLiPSE is now closed!
Thank you to all sites and families for the continued support!

Final total:
 0 0 0
The final participant was recruited by
University Hospital Southampton on 7th April 2018.
Well done to all involved!

EcLiPSE Overview

The EcLiPSE study is trying to find out whether children and young people with long lasting seizures should be treated with a medicine called phenytoin or levetiracetam (brand name Keppra) in an emergency setting.

Phenytoin and Keppra are not new medicines and are already used in the treatment of children and young people who have seizures. However, it is currently not known which medication is better. This kind of study is the best way of finding out.

In total, there are about 25-30 hospitals that are taking part in this study across the United Kingdom.

The study will involve approximately 300 children and young people aged between 6 months and up to 18 years old.


I'm fine with this [X]

The site uses cookies, some may have been set already. Please refer to our privacy policy & cookie usage statement.
If you continue to use the site we'll assume you're happy to accept the cookies.